Loading clinical trials...
Loading clinical trials...
Expanded access Protocol to treat LHON subjects with EPI743
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Edison Pharmaceuticals Inc
NCT07258667 · Leber Hereditary Optic Neuropathy (LHON), Leber's Hereditary Optic Neuropathy (LHON), and more
NCT04381091 · Leber's Hereditary Optic Neuropathy
NCT02771379 · Leber's Hereditary Optic Neuropathy (LHON)
Doheny Eye Institute / UCLA
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions